Chemo-hyperthermia using Combat HIVEC® Study

Chemo-hyperthermia using Combat HIVEC® Study

Non–muscle–invasive bladder cancer (NMIBC) presents a significant therapeutic challenge. Nearly 70% of NMIBC cases recur, and a considerable subset progress to muscle invasion, requiring radical cystectomy – a procedure which many patients either refuse or...